Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to MSD innovators at OxTALENT 2017

Innovation

The OxTALENT annual awards recognise members of the University who have made innovative use of digital technology in learning/teaching and outreach/public engagement.

MSD innovators took all three places on the podium in the Public Engagement category [http://blogs.it.ox.ac.uk/oxtalent/2996]

 Winners: Andrew Pollard, Sarah Loving & Yama Farooq for The Vaccine Knowledge Project

Runners-up: Scott Billings, Ellena Smith, Kate Nation, Jacqueline Pumphrey, Zoltan Molnar & Holly Bridge for Brain Diaries

Honourable Mention: Chris Paton, Mike English, Hilary Edgcombe, Niall Winters, Anne Geniets & Jakob Rossner for LIFE: Life-Saving Instruction for Emergencies

 MSD also received awards in:

 Innovative teaching and learning with technology [http://blogs.it.ox.ac.uk/oxtalent/2990]

 Joint Runners-up: Nicola Barclay, Simon Kyle, Colin Espie, Christopher-James Harvey, Sumathi Sekaran & Damion Young for The Oxford online programme in Sleep Medicine

Honourable Mention: Jennifer Brown for Development of ‘Virtual Microscopy’ and online assessment modules for the Laboratory Medicine course

 Innovation Challenges [http://blogs.it.ox.ac.uk/oxtalent/3033]

 Runner-up: Jon Mason for Chooser: Simple, flexible option choosing

 

 

Similar stories

Investigating New Treatment for Schizophrenia

General Innovation Research

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.

£100 million donation from Ineos to create new institute to fight antimicrobial resistance

Awards and Appointments General Innovation

A new state of the art institute for antimicrobial research is to open at Oxford University thanks to a £100 million donation from Ineos.

University spinout PepGen awarded major financing to target Duchenne muscular dystrophy

Awards and Appointments General Innovation

PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.

Evox Therapeutics announces launch of strategic collaboration with the University of Oxford

General Innovation

Collaboration with world-renowned research centre to accelerate development of exosome therapies for rare diseases

BioEscalator’s resident biotech Base Genomics acquired by Exact Sciences

General Innovation

Oxford Sciences Innovation (OSI) recently announced the acquisition of its portfolio company, Base Genomics, by US-based early cancer diagnostic leaders, Exact Sciences, for $410m. The partnership will enable Base Genomics to significantly accelerate its clinical and commercial development here in Oxford, potentially unlocking a new era of preventative medicine and improved patient outcomes.

Novel COVID-19 Antibody Therapy Candidates Identified by Leading UK Biotech Consortium

Coronavirus COVID-19 Innovation Research